BackOrthofix Medical Overview
Orthofix Medical Inc

Orthofix Medical Target Price

See Orthofix Medical's analyst price targets ($15) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$12.2

Average Target Price

$15.4026.2% upside

5 analysts in the last 4 months

High: $18 | Low: $12

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-06Barrington$1739.3% upsideOpen
2026-05-22Barrington$1523% upsideOpen
2026-05-22UBS$1523% upsideOpen
2026-05-21Cowen & Co.$121.6% downsideOpen
2026-05-21Canaccord GenuityCaitlin Burrows$1847.5% upsideOpen
2026-03-09Stifel Nicolaus$1847.5% upsideOpen
2025-11-05BarringtonMichael Petusky$1847.5% upsideOpen
2025-10-28Stifel Nicolaus$2280.3% upsideOpen
2024-11-08Stifel NicolausMathew Blackman$2496.7% upsideOpen
2022-06-28Stifel NicolausMathew Blackman$31154.1% upsideOpen

Orthofix Medical (OFIX) FAQ

Orthofix Medical's target price stands at $15. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $15 for OFIX implies 26.2% upside versus today's price ($12.2). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Orthofix Medical's target price evolved across reporting periods, while the comparison chart places OFIX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Orthofix Medical's reading of $15 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.